1. Home
  2. CVV vs BCTX Comparison

CVV vs BCTX Comparison

Compare CVV & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVD Equipment Corporation

CVV

CVD Equipment Corporation

SELL

Current Price

$4.35

Market Cap

27.9M

Sector

Technology

ML Signal

SELL

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

SELL

Current Price

$3.06

Market Cap

28.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CVV
BCTX
Founded
1982
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
28.8M
IPO Year
2007
2025

Fundamental Metrics

Financial Performance
Metric
CVV
BCTX
Price
$4.35
$3.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
56.5K
★ 63.1K
Earning Date
11-05-2026
12-10-2026
Dividend Yield
N/A
N/A
EPS Growth
17.86
★ 88.79
EPS
★ 1.36
N/A
Revenue
★ $41,128,639.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$250.50
P/E Ratio
$3.20
★ N/A
Revenue Growth
★ 96.27
N/A
52 Week Low
$2.96
$2.60
52 Week High
$9.10
$13.09

Technical Indicators

Market Signals
Indicator
CVV
BCTX
Relative Strength Index (RSI) 52.11 39.41
Support Level $3.91 $2.97
Resistance Level $4.31 $3.74
Average True Range (ATR) 0.28 0.28
MACD 0.07 -0.02
Stochastic Oscillator 64.41 7.27

Price Performance

Historical Comparison
CVV
BCTX

About CVV CVD Equipment Corporation

CVD Equipment Corp designs, develops, and manufactures a broad range of equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as industrial applications, and research. It currently conducts its business through two reportable segments: CVD Equipment, which designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems. Its target markets are aerospace & defense and industrial, microelectronics / high power electronics, and EV battery materials / energy storage.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing targeted immunotherapies to transform cancer care. Its Bria-IMT targeted immunotherapy is being developed in combination with the immune checkpoint inhibitor Retifanlimab in a pivotal Phase 3 study in metastatic breast cancer. The Company's operations focus on the research and development of its immunotherapy product candidates and related supporting activities.

Share on Social Networks: